Log on / register
Feedback | Support | My details
Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin.
Molhoek KR, Brautigan DL, Slingluff CL
J Transl Med 2005 Oct 28, 3:39
[Full text] [PubMed] [Related articles]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
Molhoek KR, Griesemann H, Shu J, Gershenwald JE, Brautigan DL, Slingluff CL
Cancer Res 2008 Jun 1, 68:4392-7
 [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.